About Padagis
Padagis is a company based in Allegan (United States) founded in 2021 was acquired by Altaris in July 2021. The company has 418 employees as of December 31, 2021. Padagis offers products and services including Extended Topicals and Paragraph IV Products. Padagis operates in a competitive market with competitors including Novartis, Catalent, Surrozen, Biotage and Curia, among others.
- Headquarter Allegan, United States
- Employees 418 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Padagis
Padagis offers a comprehensive portfolio of products and services, including Extended Topicals and Paragraph IV Products.
Includes creams, ointments, and gels for prescription medical treatments.
Generic drugs that challenge and manufacture against branded patents.
People of Padagis
Unlock access to complete
Funding Insights of Padagis
Detailed funding history for Padagis
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Padagis
Padagis has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Altaris.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
PE firm invests in the US
|
Locked | Locked | Locked |
Investor details for Padagis
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Padagis
Investment portfolio details for Padagis
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Padagis
Detailed financials for Padagis
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Padagis Comparisons
Peer comparison for Padagis
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Padagis
Padagis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Novartis, Catalent, Surrozen, Biotage and Curia, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
R&D focused on manufacturing of drugs for multiple therapeutic areas
|
|
| Locked | Locked | Locked |
CDMO offering drug and biologics development services
|
|
| Locked | Locked | Locked |
Selective Wnt agonists are developed for human tissue regeneration.
|
|
| Locked | Locked | Locked |
Organic synthesis, analytical, and peptide chemistry services for drug discovery and development
|
|
| Locked | Locked | Locked |
Drug research, development, testing, and consulting services are provided.
|
|
| Locked | Locked | Locked |
Provides contract research, development, and manufacturing services for biologic drugs.
|
Detailed competitors of Padagis
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Padagis
Complete news archive for Padagis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Padagis
Padagis was founded in 2021.
Padagis is headquartered in Allegan, United States. It is registered at Allegan, Michigan, United States.
Sharon Kochan is the current CEO of Padagis.
As of Dec 31, 2021, the latest employee count at Padagis is 418.
Padagis was founded in 2021 and is headquartered in Allegan, United States. Operations focus on the pharmaceutical sector, where design and manufacturing services for generic prescription (Rx) and over-the-counter (OTC) products are provided. These services support the development and production of pharmaceutical items, with activities centered in the U.S. market. Leadership includes Sharon Kochan as CEO.
Padagis offers Extended Topicals and Paragraph IV Products.
Padagis has 1 investor. Key investors include Altaris.